Exchange: NASDAQ·Updated 07:15 AM EDT
SLXN logo

SLXNSilexion Therapeutics Ltd

$2.62
$0.1063
(4.24%)
Pre-Market
Prev Close $2.51
Reported EarningsMay 18
Mkt Cap$2.75M
Vol20.00
News
all
press releases
Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation
Emerging biotech and biologics names exploded onto traders’ radar Wednesday as a wave of clinical milestones, regulatory momentum, strategic acquisitions, and high-volume technical breakouts fueled aggressive speculation across the sector. $HCWB, $TGNT, $KBLB, $SLS, $RKDA, $ROIV, $SLXN
24-7 Market News
More News
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why
Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.
Stocktwits
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%
“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.
Stocktwits
Silexion Stock Hits Record Intraday Low After Pricing $5M Offering, But Retail Excitement Over Cancer Data Endures
Priced at $1.35 per share and warrant, the offering was below Wednesday’s closing price of $1.56.
Stocktwits
5 Stocks Retail Investors Are Most Bullish On At Mid-Day
Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.
Stocktwits
<
...
1
>

Advertisement|Remove ads.